
Gender-Questioning Children Must Be 11 to Join Puberty Blocker Trial
A clinical trial for gender-questioning children using puberty blockers will require participants to be at least 11 years old. The Pathways Trial, previously paused due to safety concerns, has strengthened safeguards, including a minimum age and parental consent. Legal challenges and ethical debates continue.












